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positive margins [OR 4.15(3.15-5.47); p < 0.0001], ECE [OR 
5.78(4.41-7.58); p < 0.0001], SVI [OR 4.10(2.88-5.85); p < 
0.0001], and Gleason score 8-10 [OR 2.90(1.97-4.26); p < 
0.0001]. Cancer centre was also predictive of referral rates 
(range 5.68% to 65.63% p < 0.0001). Patients seen by RO post-RP 
were almost twice as likely to have seen RO prior to RP [OR 
1.94(1.51-2.49); p < 0.0001]. Patient age, distance from an RT 
facility, neighbourhood income quintile, RP centre surgical 
volume, and affiliation of RP hospital with a cancer centre were 
not associated with the likelihood of RO consultation. On 
multivariate analysis of determinants of receiving ART, younger 
age [OR 1.029(1.004-1.054); p = 0.024] and adverse pathologic 
features, including positive margins [OR 4.34(3.09-6.11); p < 
0.0001], ECE [OR 8.13(5.26-12.50); p < 0.0001], SVI [OR 
3.33(2.32-4.81); p < 0.0001], and Gleason score 8-10 [OR 
2.53(1.68-3.82); p < 0.0001] remained strongly associated with 
the use of ART. The use of ART varied significantly across cancer 
centre regions (range 1.14% to 19.37% of all RP patients, p = 
0.0002). 
Conclusions: Over 40% of patients have high-risk features 
following RP and may benefit from ART, but many do not receive 
early RO referral. Cancer Centre is strongly predictive of both 
referral and ART use. An effort should be made to understand 
and reduce large inter-centre variations in access to RT post-RP 
for patients with high-risk prostate cancer. 
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Purpose: Choroidal metastases are an ominous sign of advanced 
systemic disease and a substantial source of morbidity causing 
visual impairment in many. External beam radiotherapy (RT) is 
an effective palliative treatment for choroidal metastases aimed 
at preserving vision and obtaining local tumour control. This 
study reports the outcomes of delivery of 20 Gy in 5 fractions in 
this palliative setting. 
Methods and Materials: This retrospective chart review included 
patients treated in the Ocular Oncology clinic at a large tertiary 
cancer centre who received RT (20 Gy in 5 fractions) for 
choroidal metastases between January 1999 and November 2012. 
Primary outcome measures were change in visual acuity and 
tumour response. Secondary outcomes included toxicities of RT 
(CTCAE version 4.0), tumour control, and overall survival (OS) 
from the date of choroidal metastases diagnosis. The following 
variables were evaluated using univariate and multivariable cox 
regression models for their association with OS: tumour 
histology, presence of symptoms, number of choroidal 
metastases, unilateral versus bilateral choroidal involvement, 
and interval between primary cancer diagnoses and choroidal 
metastases. 
Results: Fifty-five patients with 71 involved eyes were 
evaluated. Median follow up was 12 months (range 1-49). 
Decreased vision was the presenting symptom in 43 eyes (61%). 
Visual acuity improved from a median of 20/70 at baseline to 
20/40 at last follow up, and remained stable or improved in 56 
eyes (80%). Tumour shrinkage was observed in 64 eyes (91%) with 
complete response in 47 eyes (67%). Metastases progressed in 
four eyes (6%). Of the 39 patients presenting with unilateral 
choroidal disease (all were treated with a single lateral field, 
which resulted in 50-80% of the prescription dose to the 
contralateral choroid), only one developed contralateral 
choroidal metastases at 11 months after RT. Median survival 
after diagnosis of choroidal metastases was 13 months (95% CI: 
9-19) with Kaplan-Meier estimates of 50% (36-62), 23% (12-35), 
and 8% (3-18) at one, two, and three years, respectively. Acute 
toxicities were not experienced in 49 (89%) patients while five 
patients had transitory eye dryness (Grade 1) and one patient 
had episcleritis (Grade 1). Late toxicities included seven (10%) 
with optic neuropathy, four (6%) with cataracts, one (1%) with 
retinopathy, five (7%) with pigmentary maculopathy, and one 
(1%) with neovascular glaucoma. No variables were statistically 
significantly associated with OS. 
Conclusions: A short fractionation schedule of 20 Gy in 5 
fractions is a well-tolerated treatment that effectively preserves 
vision and gains local tumour control for many patients with 
choroidal metastases. This approach minimizes time spend in 
hospital for this palliative patient population and compares 
favourably to previously reported series for both outcomes and 
toxicities. 
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Purpose: The Spinal Instability Neoplastic Score (SINS) was 
developed to identify patients requiring assessment by a spine 
surgeon. Patients are stratified into three groups: score 0-6 
(stable spine, no referral), 7-12 (potentially unstable, consider 
referral), and 13-18 (unstable, referral required). Purposes of 
study: (1) characterize the scores seen in a consecutive cohort 
of patients treated with spinal radiotherapy (RT) (2) assess 
referral patterns to spinal surgery (3) identify whether high SINS 
was prognostic of worse outcome following palliative RT. 
Methods and Materials: We retrospectively reviewed 
consecutive patients receiving palliative spine RT between 2012 
and 2013. The SINS was calculated based on CT simulation scan 
and clinical assessment. Charts were reviewed. Data analyzed 
using Kaplan-Meier and Cox models. A threshold of seven 
stratified patients into low- versus high-SINS groups. 
Results: One hundred and ninety-six patients were included. 
Patient demographics (median(range)): Age 66 (34-95), ECOG 2 
(0-4), Charlson Comorbidity Score 0 (0-4). Follow up was 6.1 (0.1-
42.3) months in all patients and 28.5 (0.2-42.3) months in living 
patients. By time of analysis, 83.7% had died.  
Median (range) SINS was 7 (1-18). SINS was 0-6, 7-12, and 13-18 
in 34%, 59% and 7% of patients. SINS indicated potentially or 
unstable spine in 84%, 63%, 53%, and 62% of breast, lung, 
prostate, and other cancer patients. Nineteen patients were 
referred to spine surgery (13 before and six after RT), with a 
surgery performed in zero of two patients with SINS 0-6, three of 
14 with SINS 7-12, and one of three with SINS 13-18. Stable spine 
on assessment, intact neurological status, and poor life 
expectancy were the most common reasons not to pursue surgery 
amongst surgically referred patients. SINS > 7, age, ECOG > 2, 
cancer type, solitary vertebral metastasis, control of primary, 
systemic therapy, and estimated prognosis were not predictive 
of surgery referral on univariate analysis. Outcomes 
(median(95%CI)) did not differ between low- versus high-SINS 
groups. Overall survival was 7.1 months (4.4-9.8, low) versus 6.4 
months (2.1-10.5, high), p = 0.262. Time to ECOG  ≥ 3 was 17.1 
months (5.2-28.9, low) versus 22.0 months (20.8-23.1, high), p = 
0.167. Freedom from subsequent intervention (RT or surgery) to 
the same vertebrae at one year was 81.7 +/- 5.5% (low) versus 
79.0% +/- 5.4% (high), p = 0.211. Ambulation at one year was 
84.2 +/- 4.7% (low) versus 90.2 +/- 4.0% (high), p = 0.085. 
Conclusions: Most patients with unstable or potentially unstable 
spines according to SINS were not referred to a spine surgeon. 
Higher SINS did not predict for worse survival, functional 
outcomes, or increased need for subsequent intervention. It is 
uncertain whether SINS would be predictive of outcomes in a 
cohort with better performance status. At the time of this study, 
many physicians were not using SINS to guide referral decisions. 
Whether and how SINS should be used to select patients for 
surgery requires further study. 
 
 
